参考文献
[1]. World Health Organization. WHO guidelines for pharmacological management of pandemic (H1N1) 2009 influenza and other influenza viruses.Geneva, Switzerland; 2010
[2]. W.I.V. Influenza [Internet]. Wetenschappelijk Instituut Volksgezondheid; 2017. https://www.wiv-isp.be/nl/gezondheidsonderwerpen/influenza-0 [Accessed 15-12-2017]
[3]. Vanderbeke L, Spriet I, Breynaert C, et al. Invasive pulmonary aspergillosis complicating severe influenza: epidemiology, diagnosis and treatment[J]. Current opinion in infectious diseases, 2018, 31(6): 471-480.
[4]. Schauwvlieghe A F A D, Rijnders B J A, Philips N, et al. Invasive aspergillosis in patients admitted to the intensive care unit with severe influenza: a retrospective cohort study[J]. The Lancet Respiratory Medicine, 2018, 6(10): 782-792.
[5]. Wauters J, Baar I, Meersseman P, et al. Invasive pulmonary aspergillosis is a frequent complication of critically ill H1N1 patients: a retrospective study[J]. Intensive care medicine, 2012, 38(11): 1761-1768.
[6]. Martin-Loeches I, J. Schultz M. Vincent JL, et al. Increased incidence of coinfection in critically ill patients with influenza. Intensive Care Med 2017;43:48–58.
[7]. Alshabani K, Haq A, Miyakawa R, et al. Invasive pulmonary aspergillosis in patients with influenza infection: report of two cases and systematic review of the literature[J]. Expert review of respiratory medicine, 2015, 9(1): 89-96.
[8]. Ku Y H, Chan K S, Yang C C, et al. Higher mortality of severe influenza patients with probable aspergillosis than those with and without other coinfections[J]. Journal of the Formosan Medical Association, 2017, 116(9): 660-670.
[9]. Van De Veerdonk F L, Kolwijck E, Lestrade P P A, et al. Influenza-associated aspergillosis in critically ill patients[J]. American Journal of Respiratory and Critical Care Medicine, 2017, 196(4): 524-527.
[10]. Takazono T, Izumikawa K. Recent Advances in Diagnosing Chronic Pulmonary Aspergillosis[J]. Frontiers in microbiology, 2018, 9.
[11]. Pfeiffer C D, Fine J P, Safdar N. Diagnosis of invasive aspergillosis using a galactomannan assay: a meta-analysis[J]. Clinical Infectious Diseases, 2006, 42(10): 1417-1727.
[12]. Diagnosis and management of Aspergillus diseases: executive summary of the 2017 ESCMID-ECMM-ERS guideline
本文荟萃自,只做学术交流学习使用,不做为临床指导,本文观点不代表数字重症 ICU.CN立场。
微信扫一扫